Biopharmaceuticals Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	150 Pages	Coherent Market Insights	June, 2023	CMI18049086

Best Price Guarantee
Price	from $4,500
Length	150 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049086

Biopharmaceuticals Market, By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, and Other Product Types), By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, and Other Diseases), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

A biopharmaceutical is a therapeutic drug manufactured in, extracted from, or semi-synthesized from biological sources. Biopharmaceuticals include a wide range of products such as vaccines, therapeutic proteins, blood and blood components, tissues, etc. Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science.

Market Dynamics:

Increasing burden of chronic, infectious, and neurological diseases, growing geriatric population, increase in research and development (R&D), and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global biopharmaceuticals market.

For instance, in October 2022, Phanes Therapeutics, Inc. received clearance from the US Food and Drug Administration (FDA) to commence Phase I studies with PT217, its anti-Delta-like ligand 3 (DLL3)/anti-Cluster of differentiation 47 (CD47) bispecific antibody being developed for patients with small cell lung cancer (SCLC) and other neuroendocrine cancer. PT217 recently been granted an orphan drug designation by the FDA for the treatment of SCLC.

Key features of the study:

This report provides in-depth analysis of the global biopharmaceuticals market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global biopharmaceuticals market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include Amgen Inc., GlaxoSmithKline PLC, Pfizer Inc., Novo Nordisk AS, Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, Abbvie Inc., and F. Hoffmann-La Roche Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global biopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceuticals market.

Detailed Segmentation:

Global Biopharmaceuticals Market, By Product Type:

Monoclonal Antibodies

Recombinant Growth Factors

Purified Proteins

Recombinant Proteins

Recombinant Hormones

Vaccines

Recombinant Enzymes

Cell and Gene Therapies

Synthetic Immunomodulators

Other Product Types

Global Biopharmaceuticals Market, By Therapeutic Application:

Oncology

Inflammatory and Infectious Diseases

Autoimmune Disorders

Metabolic Disorders

Hormonal Disorders

Cardiovascular Diseases

Neurological Diseases

Other Diseases

Global Biopharmaceuticals Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Company Profiles:

Amgen Inc.

Abbvie Inc.

GlaxoSmithKline PLC

Pfizer Inc.

Novo Nordisk AS

Novartis AG

Johnson & Johnson

Eli Lilly and Company

Bristol-Myers Squibb Company

F.Hoffmann-La Roche Ltd.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Therapeutic Application; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rise in patient pool and growing geriatric population; High-end manufacturing requirements; The outbreak of COVID-19 (global pandemic); Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Biopharmaceuticals Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Biopharmaceuticals Market, By Product Type, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Monoclonal Antibodies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Recombinant Growth Factors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Purified Proteins; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Recombinant Proteins; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Recombinant Hormones; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Recombinant Enzymes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Cell and Gene Therapies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Synthetic Immunomodulators; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Other Product Types; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
6. Global Biopharmaceuticals Market, By Therapeutic Application, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; Oncology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Inflammatory and Infectious Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Autoimmune Disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Metabolic Disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Hormonal Disorders; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Cardiovascular Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Neurological Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn); Other Diseases; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
7. Global Biopharmaceuticals Market, By Geography, 2018-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018– 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2018-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2018-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2018-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2018-2030,(US$ Bn); Middle East and Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2018-2030,(US$ Bn)
8. Competitive Landscape: Amgen Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Abbvie Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; GlaxoSmithKline PLC; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Pfizer Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Novo Nordisk AS; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Johnson & Johnson; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Eli Lilly and Company; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Bristol-Myers Squibb Company; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; F. Hoffmann-La Roche Ltd.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views
9. Section: Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Biopharmaceuticals Market” - forecast to 2030